Nordic Precision Medicine Forum

27-28 April 2023

The Lifebit team joined the Nordic Precision Medicine Forum to share and discuss global efforts to deliver federated Trusted Research Environments to help transform the future of healthcare and the life sciences industry.

 

Lifebit's Chief Business Development Officer Thorben Seeger presented opportunities for scaling precision medicine through federation, while maintaining security, privacy, and data access. Thorben also provided an update on our partnerships with Greece, the UK and Denmark.

April 27-28 2023
München
Bryggeriet Torkel
Knutssonsgatan
2, 118 25
Stockholm
Booth #M8
Precision Medicine
AI & Data
Digital Health
Lifebit Speakers
The Nordic Precision Medicine forum brought industry leaders together to exchange ideas and insights on the significance of precision medicine, AI and Data in healthcare, and digital health-related issues. We shared insights into how we provide federated solutions for population genomics initiatives, helping to tackle the obstacles usually associated with patient data accessibility and usability. Lifebit's Chief Business Development Officer Thorben Seeger spoke about global efforts to deliver national Trusted Research Environments at scale. He also provided an update on our partnerships with Greece, the UK and Denmark.

″Lifebit’s presence in these important conferences and networking with key opinion leaders enables us to understand the local needs of Nordic, Scandinavia, and Baltic biobanks and their national genomic initiatives. ″

-Karl Quinn, Director of Biobanks (EMEA), Lifebit
München Bryggeriet
Torkel Knutssonsgatan 2, 118 25
Stockholm
Münchenbryggeriet is centrally located on Södermalm in Stockholm
Thorben Seeger
Chief Business Development Officer, Lifebit
Thorben Seeger leads Lifebit’s commercial operations. With over 14 years of experience in enterprise technology solutions, his innovation in the genomics field has established Lifebit as the leading software technology powering precision medicine programs worldwide, such as Genomics England & Hong Kong Genome Project. In addition, he guides partnerships with pharma giants like Boehringer Ingelheim, where Lifebit will deliver AI-powered insights.

Subscribe to our mailing list

Sign up below to receive the latest news, events and updates from Lifebit.

More like this